Lek d.d., a prominent pharmaceutical company headquartered in Slovenia (SI), has been a key player in the industry since its establishment in 1946. With a strong presence in Central and Eastern Europe, Lek d.d. focuses on the development, production, and marketing of generic and innovative medicines, particularly in the fields of oncology, cardiovascular health, and central nervous system disorders. Renowned for its commitment to quality and innovation, Lek d.d. offers a diverse portfolio of products that cater to various therapeutic areas. The company has achieved significant milestones, including its integration into the Sandoz division of Novartis, enhancing its market position and global reach. Lek d.d. continues to be recognised for its contributions to healthcare, making it a trusted name in the pharmaceutical landscape.
We don't have data for Lek d. d., but we can show you information about their parent organization instead.
View parent company